Spotlight On... India hopes for a clinical trial upswing; Pierre Fabre taps BioAscent for compound management; and much more...

India's Council of Medical Research is pushing for a renewed emphasis on clinical trials in the country, hoping to reverse a downturn spurred by tightened regulations and safety concerns. The group is requesting government reforms that might make studies faster and easier to get running, pointing out that the country's high rates of infectious disease could benefit from a boost in clinical research. More

> Pierre Fabre signed a deal with service provider BioAscent Discovery that tasks the company with managing its library of drug compounds. News

> Pfizer ($PFE) is reportedly nearing a deal with Russian drug manufacturer Polysan to produce its products in the country. Story

Suggested Articles

Symphony Health has inked a new deal with Close-Up International aimed at boosting its global data services.

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.